SCHEMBL21474035

SCHEMBL21474035

Cc1ncc(Cl)cc1C(=O)NC1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRHR1 P34998 19/20 0.61
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ CRHR2 Q13324 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405389 0.88 CRHR1 (0.64) CRHR1CRHR2
SCHEMBL27816992 0.86 CRHR1 (0.63) CRHR1CRHR2
SCHEMBL24405601 0.86 LMNA (0.56) NPC1RAB9A
SCHEMBL24405365 0.86 LMNA (0.56) NPC1RAB9A
SCHEMBL27998886 0.85 CRHR1 (0.61) CRHR1CRHR2
SCHEMBL27998885 0.85 CRHR1 (0.61) CRHR1CRHR2
SCHEMBL2317531 0.84 CRHR1 (0.60) CRHR1CRHR2
SCHEMBL30615456 0.84 CRHR1 (0.70) CRHR1CRHR2
SCHEMBL1850200 0.84 CRHR1 (0.70) CRHR1CRHR2
SCHEMBL2317525 0.84 CRHR1 (0.60) CRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
WO-2022071484-A1 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2022-04-07 — — WO disclosed
WO-2019198692-A1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2019-10-17 — — WO disclosed
Send feedback